ReviewOncoTargets and therapy2014

Clinical efficacy and safety of imatinib in the management of Ph(+) chronic myeloid or acute lymphoblastic leukemia in Chinese patients.

Yu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.